What is the market doing?
What the tape says about LLY
Lilly (Eli) is +61% over the past year while the S&P 500 is +23%: 38 points ahead of the market.
+61%
1-year return · S&P 500 +23%
- vs 200-day average
- +15%
vs 200-day average · a clear uptrend
- RSI (14)
- 50
RSI (14) · neutral
- Below its 52-week high
- −7.0%
Below its 52-week high
Details›
- Last close2026-08-26
- $1,189.68
- 1 monthS&P 500 +3.7%
- +0.35%
- 1 yearS&P 500 +23%
- +61%
- 5 yearsS&P 500 +87%
- +412%
- vs 50-day average$1,164.81
- +2.1%
- 52-week high
- $1,279.81
- 52-week low
- $621.26
- Annualised volatility
- 39%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-06-30
- −$340M
| Year | Return |
|---|---|
| 2026 (year to date) | +11% |
| 2025 | +40% |
| 2024 | +33% |
| 2023 | +61% |
| 2022 | +34% |
| 2021 | +66% |
| 2020 | +31% |
| 2019 | +16% |
| 2018 | +40% |
| 2017 | +18% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 6 of 10 | +2.9% |
| Feb | 10 | 6 of 10 | +2.4% |
| Mar | 10 | 7 of 10 | +1.1% |
| Apr | 10 | 7 of 10 | +3.0% |
| May | 10 | 6 of 10 | +3.4% |
| Jun | 10 | 9 of 10 | +5.1% |
| Jul | 11 | 6 of 11 | +0.84% |
| Aug | 11 | 5 of 11 | +3.7% |
| Sep | 10 | 5 of 10 | −0.11% |
| Oct | 10 | 6 of 10 | +1.1% |
| Nov | 10 | 7 of 10 | +4.9% |
| Dec | 10 | 4 of 10 | +4.0% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Drug Manufacturers - General
Ranks #1 of 16 by Smart Score